Riam Shammaa

Director/Board Member bei DEFENCE THERAPEUTICS INC.

Health Technology

Profil

Riam Shammaa is the founder of IntelliStem Technologies, Inc. where he holds the title of Chief Executive Officer since 2019.
Dr. Shammaa is also the founder of Pallianera Pharma, Inc. Dr. Shammaa's current job is as an Independent Director at Defence Therapeutics Inc since 2021.

Aktive Positionen von Riam Shammaa

Unternehmen	Position	Beginn
DEFENCE THERAPEUTICS INC.	Director/Board Member	09.11.2021
IntelliStem Technologies, Inc. IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation.	Chief Executive Officer	04.02.2019

Alle aktiven Positionen von Riam Shammaa

Ehemalige bekannte Positionen von Riam Shammaa

Unternehmen	Position	Ende
Pallianera Pharma, Inc.	Founder	-

Sehen Sie sich die Erfahrung von Riam Shammaa im Detail an

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Riam Shammaa im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	1
DEFENCE THERAPEUTICS INC.	Health Technology

Private Unternehmen	2
IntelliStem Technologies, Inc. IntelliStem Technologies, Inc. BiotechnologyHealth Technology IntelliStem Technologies, Inc. is a Canadian biotechnology company that specializes in engineering stem cells for the development of next-generation cell therapy products. The private company is based in Toronto, Canada. The company's proprietary cell platforms, including Super Sentinel Cells (SSCs) for cancer therapeutics and IntelliCells for drug discovery and target identification, are genetically engineered. IntelliStem is currently moving into human clinical trials. The company was founded by Riam Shammaa, who has been the CEO since incorporation.	Health Technology
Pallianera Pharma, Inc.